These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29982217)

  • 1. Oral propranolol for prevention of threshold retinopathy of prematurity (ROPROP): protocol of a randomised controlled trial.
    Bührer C; Erdeve Ö; Bassler D; Bar-Oz B
    BMJ Open; 2018 Jul; 8(7):e021749. PubMed ID: 29982217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of propranolol in very preterm infants at the risk of retinopathy of prematurity: Which newborn and when?
    Ozturk MA; Korkmaz L
    Int Ophthalmol; 2019 Sep; 39(9):1921-1930. PubMed ID: 30229439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral propranolol in prevention of severe retinopathy of prematurity: a systematic review and meta-analysis.
    Stritzke A; Kabra N; Kaur S; Robertson HL; Lodha A
    J Perinatol; 2019 Dec; 39(12):1584-1594. PubMed ID: 31570797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.
    Filippi L; Cavallaro G; Fiorini P; Daniotti M; Benedetti V; Cristofori G; Araimo G; Ramenghi L; La Torre A; Fortunato P; Pollazzi L; la Marca G; Malvagia S; Bagnoli P; Ristori C; Dal Monte M; Bilia AR; Isacchi B; Furlanetto S; Tinelli F; Cioni G; Donzelli G; Osnaghi S; Mosca F
    BMC Pediatr; 2010 Nov; 10():83. PubMed ID: 21087499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.
    Filippi L; Cavallaro G; Berti E; Padrini L; Araimo G; Regiroli G; Bozzetti V; De Angelis C; Tagliabue P; Tomasini B; Buonocore G; Agosti M; Bossi A; Chirico G; Aversa S; Pasqualetti R; Fortunato P; Osnaghi S; Cavallotti B; Vanni M; Borsari G; Donati S; Nascimbeni G; la Marca G; Forni G; Milani S; Cortinovis I; Bagnoli P; Dal Monte M; Calvani AM; Pugi A; Villamor E; Donzelli G; Mosca F
    BMC Pediatr; 2017 Jul; 17(1):165. PubMed ID: 28709412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term Refractive Effects of Propranolol Hydrochloride Prophylaxis on Retinopathy of Prematurity in Very Preterm Newborns.
    Korkmaz L; Karaca C; Akin MA; Bastug O; Sahiner M; Ozdemir A; Gunes T; Ozturk MA; Kurtoglu S
    Curr Eye Res; 2018 Feb; 43(2):213-217. PubMed ID: 29135357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral propranolol in early stages of retinopathy of prematurity.
    Bancalari A; Schade R; Muñoz T; Lazcano C; Parada R; Peña R
    J Perinat Med; 2016 Jul; 44(5):499-503. PubMed ID: 26845715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic propranolol for prevention of ROP and visual outcome at 1 year (PreROP trial).
    Sanghvi KP; Kabra NS; Padhi P; Singh U; Dash SK; Avasthi BS
    Arch Dis Child Fetal Neonatal Ed; 2017 Sep; 102(5):F389-F394. PubMed ID: 28087723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Propranolol: A New Treatment for Infants with Retinopathy of Prematurity?
    Bührer C; Bassler D
    Neonatology; 2015; 108(1):49-52. PubMed ID: 25968340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial.
    Phelps DL; Watterberg KL; Nolen TL; Cole CA; Cotten CM; Oh W; Poindexter BB; Zaterka-Baxter KM; Das A; Lacy CB; Scorsone AM; Walsh MC; Bell EF; Kennedy KA; Schibler K; Sokol GM; Laughon MM; Lakshminrusimha S; Truog WE; Garg M; Carlo WA; Laptook AR; Van Meurs KP; Carlton DP; Graf A; DeMauro SB; Brion LP; Shankaran S; Orge FH; Olson RJ; Mintz-Hittner H; Yang MB; Haider KM; Wallace DK; Chung M; Hug D; Tsui I; Cogen MS; Donahue JP; Gaynon M; Hutchinson AK; Bremer DL; Quinn G; He YG; Lucas WR; Winter TW; Kicklighter SD; Kumar K; Chess PR; Colaizy TT; Hibbs AM; Ambalavanan N; Harmon HM; McGowan EC; Higgins RD;
    JAMA; 2018 Oct; 320(16):1649-1658. PubMed ID: 30357297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trial.
    Teofili L; Papacci P; Dani C; Cresi F; Remaschi G; Pellegrino C; Bianchi M; Ansaldi G; Campagnoli MF; Vania B; Lepore D; Franco FGS; Fabbri M; de Vera d' Aragona RP; Molisso A; Beccastrini E; Dragonetti A; Orazi L; Pasciuto T; Mozzetta I; Baldascino A; Locatelli E; Valentini CG; Giannantonio C; Carducci B; Gabbriellini S; Albiani R; Ciabatti E; Nicolotti N; Baroni S; Mazzoni A; Besso FG; Serrao F; Purcaro V; Coscia A; Pizzolo R; Raffaeli G; Villa S; Mondello I; Trimarchi A; Beccia F; Ghirardello S; Vento G
    Ital J Pediatr; 2024 Aug; 50(1):142. PubMed ID: 39113069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial.
    Hellström A; Nilsson AK; Wackernagel D; Pivodic A; Vanpee M; Sjöbom U; Hellgren G; Hallberg B; Domellöf M; Klevebro S; Hellström W; Andersson M; Lund AM; Löfqvist C; Elfvin A; Sävman K; Hansen-Pupp I; Hård AL; Smith LEH; Ley D
    JAMA Pediatr; 2021 Apr; 175(4):359-367. PubMed ID: 33523106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.
    Pediatrics; 2000 Feb; 105(2):295-310. PubMed ID: 10654946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonidine as analgesia during retinopathy of prematurity screening in preterm infants (cloROP): protocol for a randomised controlled trial.
    Carlsen Misic M; Eriksson M; Normann E; Pettersson M; Blomqvist Y; Olsson E
    BMJ Open; 2022 Sep; 12(9):e064251. PubMed ID: 36137627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial.
    Johnson L; Quinn GE; Abbasi S; Otis C; Goldstein D; Sacks L; Porat R; Fong E; Delivoria-Papadopoulos M; Peckham G
    J Pediatr; 1989 May; 114(5):827-38. PubMed ID: 2654350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study.
    McGregor ML; Bremer DL; Cole C; McClead RE; Phelps DL; Fellows RR; Oden N;
    Pediatrics; 2002 Sep; 110(3):540-4. PubMed ID: 12205257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index.
    Korkmaz L; Baştuğ O; Ozdemir A; Korkut S; Karaca C; Akin MA; Gunes T; Kurtoglu S; Ozturk MA
    Curr Eye Res; 2017 Jan; 42(1):88-97. PubMed ID: 27260268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracetamol (acetaminophen) for prevention or treatment of pain in newborns.
    Ohlsson A; Shah PS
    Cochrane Database Syst Rev; 2015 Jun; (6):CD011219. PubMed ID: 26110914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.